158 related articles for article (PubMed ID: 38618667)
1.
Niemeyer CM; Erlacher M
Haematologica; 2024 Apr; ():. PubMed ID: 38618667
[TBL] [Abstract][Full Text] [Related]
2. Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia.
Morales CE; Stieglitz E; Kogan SC; Loh ML; Braun BS
Blood Adv; 2021 Sep; 5(18):3587-3591. PubMed ID: 34464969
[TBL] [Abstract][Full Text] [Related]
3. Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.
Sachs Z; Been RA; DeCoursin KJ; Nguyen HT; Mohd Hassan NA; Noble-Orcutt KE; Eckfeldt CE; Pomeroy EJ; Diaz-Flores E; Geurts JL; Diers MD; Hasz DE; Morgan KJ; MacMillan ML; Shannon KM; Largaespada DA; Wiesner SM
Haematologica; 2016 Oct; 101(10):1190-1199. PubMed ID: 27418650
[TBL] [Abstract][Full Text] [Related]
4. Germline bi-allelic
Arfeuille C; Vial Y; Cadenet M; Caye-Eude A; Fenneteau O; Neven Q; Bonnard AA; Pizzi S; Carpentieri G; Capri Y; Girardi K; Pedace L; Macchiaiolo M; Boudhar K; Khaled MB; Chahla WA; Lutun A; Fahd M; Drunat S; Flex E; Dalle JH; Strullu M; Locatelli F; Tartaglia M; Cavé H
Haematologica; 2023 Nov; ():. PubMed ID: 37981895
[TBL] [Abstract][Full Text] [Related]
5. LNK/
Wintering A; Hecht A; Meyer J; Wong EB; Hübner J; Abelson S; Feldman K; Kennedy VE; Peretz CAC; French DL; Maguire JA; Jobaliya C; Vasquez MR; Desai S; Dulman R; Nemecek E; Haines H; Hammad M; El Haddad A; Kogan SC; Abdullaev Z; Chehab FF; Tasian SK; Smith CC; Loh ML; Stieglitz E
Haematologica; 2023 Dec; ():. PubMed ID: 38152053
[TBL] [Abstract][Full Text] [Related]
6. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
[TBL] [Abstract][Full Text] [Related]
7. Stem cell transplant for juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
Choudhary D; Sharma SK; Gupta N; Handoo A
Indian J Hematol Blood Transfus; 2014 Sep; 30(Suppl 1):40-2. PubMed ID: 25332531
[TBL] [Abstract][Full Text] [Related]
8. CD14/16 monocyte profiling in juvenile myelomonocytic leukemia.
Gadgeel M; Bagla S; Buck S; Shamoun M; Ravindranath Y
Pediatr Blood Cancer; 2020 Sep; 67(9):e28555. PubMed ID: 32648963
[TBL] [Abstract][Full Text] [Related]
9. Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
Emanuel PD
Leukemia; 2008 Jul; 22(7):1335-42. PubMed ID: 18548091
[TBL] [Abstract][Full Text] [Related]
10. Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia.
Niemeyer CM; Loh ML; Cseh A; Cooper T; Dvorak CC; Chan R; Xicoy B; Germing U; Kojima S; Manabe A; Dworzak M; De Moerloose B; Starý J; Smith OP; Masetti R; Catala A; Bergstraesser E; Ussowicz M; Fabri O; Baruchel A; Cavé H; Zwaan M; Locatelli F; Hasle H; van den Heuvel-Eibrink MM; Flotho C; Yoshimi A
Haematologica; 2015 Jan; 100(1):17-22. PubMed ID: 25552679
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutic targets for chronic myelomonocytic leukemia.
Lasho T; Patnaik MM
Best Pract Res Clin Haematol; 2021 Mar; 34(1):101244. PubMed ID: 33762099
[TBL] [Abstract][Full Text] [Related]
12. Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome.
Lasho T; Patnaik MM
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101171. PubMed ID: 32460983
[TBL] [Abstract][Full Text] [Related]
13. [Juvenile myelomonocytic leukemia: A three-case series].
Ghariani I; Jmili-Braham N; Regaieg H; Achour B; Ben Youssef Y; Sendi H; Bakir L; Kortas M
Arch Pediatr; 2016 Dec; 23(12):1264-1269. PubMed ID: 27789175
[TBL] [Abstract][Full Text] [Related]
14. Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy.
Emanuel PD; Shannon KM; Castleberry RP
Mol Med Today; 1996 Nov; 2(11):468-75. PubMed ID: 8947912
[TBL] [Abstract][Full Text] [Related]
15. The Missing LNK: Evolution from Cytosis to Chronic Myelomonocytic Leukemia in a Patient with Multiple Sclerosis and Germline SH2B3 Mutation.
Gundabolu K; Dave BJ; Alvares CJ; Cannatella JJ; Bhatt VR; Maness LJ; Al-Kadhimi ZS; Zabad RK; Cushman-Vokoun AM
Case Rep Genet; 2022; 2022():6977041. PubMed ID: 35281324
[TBL] [Abstract][Full Text] [Related]
16. Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.
Flotho C
Epigenetics; 2019 Mar; 14(3):236-244. PubMed ID: 30773984
[TBL] [Abstract][Full Text] [Related]
17. CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia.
Fluhr S; Boerries M; Busch H; Symeonidi A; Witte T; Lipka DB; Mücke O; Nöllke P; Krombholz CF; Niemeyer CM; Plass C; Flotho C
Clin Epigenetics; 2016; 8():50. PubMed ID: 27158276
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity identifies genetic changes in chronic myeloid disorders, including myeloproliferative disorders, myelodysplastic syndromes and chronic myelomonocytic leukemia.
O'Malley DP; Orazi A; Dunphy CH; Coleman BR; Marks RA; Wang M; Cheng L
Mod Pathol; 2007 Nov; 20(11):1166-71. PubMed ID: 17704756
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic/myeloproliferative neoplasms.
Cazzola M; Malcovati L; Invernizzi R
Hematology Am Soc Hematol Educ Program; 2011; 2011():264-72. PubMed ID: 22160044
[TBL] [Abstract][Full Text] [Related]
20. Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/-γc-/- mice.
Krombholz CF; Aumann K; Kollek M; Bertele D; Fluhr S; Kunze M; Niemeyer CM; Flotho C; Erlacher M
Haematologica; 2016 May; 101(5):597-606. PubMed ID: 26888021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
